GC
Grimes & Company Portfolio holdings
AUM
$3.67B
1-Year Return
12.49%
This Quarter Return
+9.6%
1 Year Return
+12.49%
3 Year Return
+42.9%
5 Year Return
+87.85%
10 Year Return
+203.44%
AUM
$3.02B
AUM Growth
+$434M
(+17%)
Cap. Flow
+$198M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
45.02%
Holding
345
New
35
Increased
173
Reduced
106
Closed
7
Top Buys
Top Sells
Sector Composition
| 1 | Technology | 13.66% |
| 2 | Healthcare | 6.53% |
| 3 | Financials | 4.68% |
| 4 | Industrials | 3.61% |
| 5 | Consumer Discretionary | 2.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Vertex Pharmaceuticals
VRTX
$101B
| $207K | 0.01% |
+509
| New | +$207K |
|
302
American Tower
AMT
$90.6B
| $207K | 0.01% |
+959
| New | +$207K |
|
303
ADMA Biologics
ADMA
$3.98B
| $205K | 0.01% |
45,267
| – | – |
|
304
PPG Industries
PPG
$24.8B
| $204K | 0.01% |
+1,367
| New | +$204K |
|
305
iShares 1-3 Year Treasury Bond ETF
SHY
$24.5B
| $201K | 0.01% |
2,445
-657
| -21% | -$53.9K |
|
306
Innoviva
INVA
$1.32B
| $194K | 0.01% |
12,099
-260
| -2% | -$4.17K |
|
307
Gladstone Capital
GLAD
$581M
| $173K | 0.01% |
8,066
-11
| -0.1% | -$235 |
|
308
Golub Capital BDC
GBDC
$3.92B
| $172K | 0.01% |
11,421
+325
| +3% | +$4.91K |
|
|
PNNT
309
Pennant Park Investment Corp
PNNT
$471M
| $168K | 0.01% |
+24,380
| New | +$168K |
|
310
Carlyle Secured Lending
CGBD
$1B
| $167K | 0.01% |
11,188
-435
| -4% | -$6.51K |
|
311
Huntington Bancshares
HBAN
$26.1B
| $165K | 0.01% |
13,010
-338
| -3% | -$4.3K |
|
312
BlackRock TCP Capital
TCPC
$610M
| $165K | 0.01% |
+14,274
| New | +$165K |
|
313
Valley National Bancorp
VLY
$5.93B
| $157K | 0.01% |
14,500
| – | – |
|
314
Trinity Capital
TRIN
$1.14B
| $157K | 0.01% |
+10,815
| New | +$157K |
|
|
CRF
315
Cornerstone Total Return Fund
CRF
$1.22B
| $150K | 0.01% |
21,741
+1,006
| +5% | +$6.96K |
|
|
FLG
316
Flagstar Financial, Inc.
FLG
$5.38B
| $140K | ﹤0.01% |
4,575
+53
| +1% | +$1.63K |
|
317
Cornerstone Strategic Value Fund
CLM
$2.32B
| $139K | ﹤0.01% |
19,600
+1,011
| +5% | +$7.15K |
|
318
Viatris
VTRS
$12.1B
| $110K | ﹤0.01% |
+10,174
| New | +$110K |
|
|
NAK
319
Northern Dynasty Minerals
NAK
$471M
| $103K | ﹤0.01% |
318,950
| – | – |
|
320
Heron Therapeutics
HRTX
$196M
| $81.4K | ﹤0.01% |
47,863
-1,116
| -2% | -$1.9K |
|
321
Rekor Systems
REKR
$135M
| $54.9K | ﹤0.01% |
16,500
+6,500
| +65% | +$21.6K |
|
322
ImmunityBio
IBRX
$2.2B
| $50.2K | ﹤0.01% |
10,000
| – | – |
|
323
Eos Energy Enterprises
EOSE
$1.99B
| $43.6K | ﹤0.01% |
+40,000
| New | +$43.6K |
|
324
Mersana Therapeutics
MRSN
$34.7M
| $36.3K | ﹤0.01% |
626
-19
| -3% | -$1.1K |
|
325
fuboTV
FUBO
$1.27B
| $31.8K | ﹤0.01% |
10,000
-50
| -0.5% | -$159 |
|